Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
格式: | Conference item |
出版: |
American Society of Hematology
2017
|